VHCAX

ETF / Mutual Fund
NASDAQ
Vanguard Capital Opportunity Fund Admiral Shares
Price Chart
Overview

About VHCAX

AUM
Volume
Avg. Volume
Expense Ratio
0.36%

Top Holdings

Eli Lilly and Co
9.56%
Amgen Inc
2.94%
Biogen Inc
2.90%
Seagen Inc Ordinary Shares
2.61%
Biomarin Pharmaceutical Inc
2.45%

Sector Allocation

Health Care33.96%
Information Technology27.96%
Industrials11.48%
Consumer Discretionary9.86%
Financials6.79%
Communication Services5.58%

Country Allocation

United States99.21%
Mexico0.21%
United Kingdom0.12%
China0.04%
Other0.42%

Fund Information

Exchange
NASDAQ
Sector
Latest News for VHCAX
Risk & Correlation Analysis
Market Correlation
1.05
Moderate Correlation
Volatility
Low (0.19)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VHCAX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VHCAX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025